
Levocetirizine (5mg) + Montelukast (10mg)
Active composition
+1 more active ingredient
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Medical applications
Milcit-M Tablet is a combination medication containing Levocetirizine (5mg) and Montelukast (10mg) designed to provide effective relief from symptoms of allergic rhinitis and asthma. The Levocetirizine component exhibits antihistamine properties, thereby reducing histamine-induced responses such as itching, sneezing, and runny nose. Montelukast, a leukotriene receptor antagonist, inhibits the production of leukotrienes, potent mediators of inflammation and bronchoconstriction. This dual-action combination allows for comprehensive management of allergic rhinitis and asthma symptoms, including nasal congestion, sneezing, runny nose, and coughing. Additionally, Milcit-M Tablet may also reduce the risk of bronchospasm, thus providing improved lung function and overall respiratory well-being. The tablet is easily administered orally, once daily, and is suitable for patients aged 6 years and above. As a prescription-only medication, Milcit-M Tablet requires medical consultation and approval prior to use.
How to use Milcit-M Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Milcit-M Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Milcit-M Tablet. Please consult your doctor.
High Risk
Milcit-M Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Milcit-M Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Milcit-M Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Milcit-M Tablet may be needed. Please consult your doctor. Limited information is available on the use of Milcit-M Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Regular Checkup
Milcit-M Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Milcit-M Tablet should be used with caution in patients with kidney disease. Dose adjustment of Milcit-M Tablet may be needed. Please consult your doctor. Use of Milcit-M Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Milcit-M Tablet

Levocetirizine (5mg) + Montelukast (10mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Medical applications
Milcit-M Tablet is a combination medication containing Levocetirizine (5mg) and Montelukast (10mg) designed to provide effective relief from symptoms of allergic rhinitis and asthma. The Levocetirizine component exhibits antihistamine properties, thereby reducing histamine-induced responses such as itching, sneezing, and runny nose. Montelukast, a leukotriene receptor antagonist, inhibits the production of leukotrienes, potent mediators of inflammation and bronchoconstriction. This dual-action combination allows for comprehensive management of allergic rhinitis and asthma symptoms, including nasal congestion, sneezing, runny nose, and coughing. Additionally, Milcit-M Tablet may also reduce the risk of bronchospasm, thus providing improved lung function and overall respiratory well-being. The tablet is easily administered orally, once daily, and is suitable for patients aged 6 years and above. As a prescription-only medication, Milcit-M Tablet requires medical consultation and approval prior to use.
How to use Milcit-M Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Milcit-M Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Milcit-M Tablet. Please consult your doctor.
High Risk
Milcit-M Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Milcit-M Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Milcit-M Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Milcit-M Tablet may be needed. Please consult your doctor. Limited information is available on the use of Milcit-M Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Regular Checkup
Milcit-M Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Milcit-M Tablet should be used with caution in patients with kidney disease. Dose adjustment of Milcit-M Tablet may be needed. Please consult your doctor. Use of Milcit-M Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Milcit-M Tablet















